medigraphic.com
Órgano de Difusión de la Asociación Académica Panamericana de Medicina Familiar A.C.

2022, Number 3

<< Back Next >>

Arch Med Fam 2022; 24 (3)

Association Between Awareness of Diabetes Mellitus and Hypertension Early Detection and its implementation in Family Medicine

Figueroa-García J, Ortíz-Montenegro A, Figueroa-Hernández MF

Language: Spanish
References: 27
Page: 159-164
PDF size: 138.56 Kb.


ABSTRACT

Objective: To analyze the association between the awareness of diabetes and hypertension early detection and its actual implementation at Primary Care. Method: An observational, analytical, and cross-sectional study was carried out in 1009 adult patients from a Family Medicine Unit in Mexico City. To determine this association sociodemographic data were collected alongside diabetes and hypertension early detection awareness data using a structured questionnaire. Variables with statistical significance were included in a multivariate binary logistic regression model to adjust the odds ratio. Results: An association between not being aware and not performing screening tests was found with values of OR=33.9; 95%; CI=21.6-53.2 for diabetes mellitus and OR=50.4; 95% CI=28.5-89.1 for hypertension, an association with being female was also found with values of OR=3.7; CI=95% 2.4-5.8 for diabetes mellitus and OR=2.5; CI=95% 1.6-3.9 for hypertension. Conclusions: There is a significant probability that lack of early diagnosis awareness activities and not carrying them out are associated in patients with diabetes and hypertension. Strengthen timely diagnosis awareness activities in the primary care population is necessary.


REFERENCES

  1. Urbina􀇦Fuentes M, Jasso􀇦Gutiérrez L, Schiavon􀇦Ermani R, Lozano R, Finkelman J. La transición de los Objetivos de Desarrollodel Milenio a los Objetivos de Desarrollo Sostenible desde la perspectiva de los determinantes sociales de la salud y la equidaden salud. Gac Med Mex. 2017;153:697-730.

  2. Carrada-Bravo T. Prevención de las enfermedades en la práctica clínica. Avances recientes y perspectivas. Revista del InstitutoNacional de Enfermedades Respiratorias. 2000;13(1):51-62.

  3. Hernández-Muñoz O. Programas integrados de salud (PREVENIMSS). Revista Médica del Instituto Mexicano del Seguro Social.2006;44(S1):1-2.

  4. Borja-Aburto VH, González-Anaya JA, Dávila-Torres J, Rascón-Pacheco RA, González-León M. Evaluation of the impact onnon-communicable chronic diseases of a major integrated primary health care program in Mexico. Family practice.2015;33(3):219-25.

  5. Miettinen OS. Reflections on preventive medicine. Preventive medicine. 2014;67:313-5.

  6. Goméz R, González E. Evaluación de la prevención de la enfermedad y la promoción de la salud: factores que deben considerarse.Facultad Nacional de Salud Pública. 2004;22(1).

  7. Gutiérrez G, Pérez-Cuevas R, Levy S, Reyes H, Acosta B, Cantón SF, et al. Strengthening preventive care programs: a permanentchallenge for healthcare systems; lessons from PREVENIMSS México. BMC Public Health. 2010;10(1):417.

  8. Bloom DE, Cafiero E, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, et al. The global economic burden of noncommunicablediseases. Program on the Global Demography of Aging; 2012.

  9. Arredondo A, Aviles R. Costs and epidemiological changes of chronic diseases: implications and challenges for health systems.PloS one. 2015;10(3):e0118611.

  10. Salleras L. La medicina clínica preventiva: el futuro de la prevención. Medicina clínica. 1994;102:5-.

  11. Etienne CF. Los determinantes sociales de la salud en las Américas. Revista Panamericana de Salud Publica. 2013;34:377-8.

  12. Moreno-Altamirano L, García-García J, Soto-Estrada G, Capraro S, Limón-Cruz D. Epidemiología y determinantes socialesasociados a la obesidad y la diabetes tipo 2 en México. Revista Médica del Hospital General de México. 2014;77(3):114-23.

  13. Molina DI, Valencia-Uribe S, Agudelo-Rojas LM. La educación a pacientes y su corresponsabilidad como herramientas terapéuticas.Revista Colombiana de Cardiología. 2017;24(2):176-81.

  14. NCBI. Awareness: NCBI; 1991 [cited 2021. Available from: https://www.ncbi.nlm.nih.gov/mesh/68001364.

  15. Prugger C, Keil U, Wellmann J, De Bacquer D, de Backer G, Ambrosio GB, et al. Blood pressure control and knowledge oftarget blood pressure in coronary patients across Europe: results from the EUROASPIRE III survey. Journal of hypertension.2011;29(8):1641-8.

  16. Rosas-Muñoz M, Chávez-Sepúlveda C, Alarcón-Hormazabal M, Godoy F, Vázquez-Aguilar P, Cea-Leiva F. Correlation betweenglycemic control and knowledge in patients with type 2 diabetes mellitus treated at the Family Health Center of the Araucaníaregion, Chile. Revista de la Facultad de Medicina. 2018;66(4):589-93.

  17. Christian JB, Bourgeois NE, Lowe KA. Cholesterol screening in US adults and awareness of high cholesterol among individualswith severe hypertriglyceridemia: National Health and Nutrition Examination Surveys 2001–2008. Journal of CardiovascularNursing. 2015;30(1):26-34.

  18. Rantanen AT, Korkeila JJA, Löyttyniemi ES, Saxén UKM, Korhonen PE. Awareness of hypertension and depressive symptoms:a cross-sectional study in a primary care population. Scandinavian journal of primary health care. 2018;36(3):323-8.

  19. Irazola V, Rubinstein A, Bazzano L, Calandrelli M, Chung-Shiuan C, Elorriaga N, et al. Prevalence, awareness, treatment andcontrol of diabetes and impaired fasting glucose in the Southern Cone of Latin America. PloS one. 2017;12(9):e0183953.

  20. Safari-Faramani R, Rajati F, Tavakol K, Hamzeh B, Pasdar Y, Moradinazar M, et al. Prevalence, Awareness, Treatment, Control,and the Associated Factors of Diabetes in an Iranian Kurdish Population. Journal of diabetes research. 2019;2019.

  21. Shamah-Levy T V-OE, Heredia-Hernández O, Romero-Martínez M, Mojica-Cuevas J, Cuevas-Nasu L, Santaella-Castell JA, Rivera-Dommarco J. Encuesta Nacional de Salud y Nutrición 2018-19: Resultados Nacionales. Cuernavaca, México: InstitutoNacional de Salud Pública, 2020.

  22. Nansseu JR, Petnga S-JN, Atangana CP, Ossa AS, Sangong SNN, Ebendeng P, et al. The general public’s knowledge of diabetesmellitus: A cross-sectional study in Cameroon. Primary care diabetes. 2019;13(2):97-105.

  23. Yen ST, Tan AK, Mustapha FI. Awareness of diabetes, hypertension, and hypercholesterolemia in Malaysia. Journal of diabetes.2017;9(9):874-83.

  24. Sandín M, Espelt A, Escolar-Pujolar A, Arriola L, Larrañaga I. Desigualdades de género y diabetes mellitus tipo 2: la importanciade la diferencia. Avances en diabetología. 2011;27(3):78-87.

  25. Castillo-Arriaga A, Delgado-Sánchez V, Carmona-Suazo JA. Percepción de riesgo familiar a desarrollar diabetes mellitus. RevistaMédica del Instituto Mexicano del Seguro Social. 2006;44(6):505-10.

  26. Gómez JF, Camacho PA, López-López J, López-Jaramillo P. Control y tratamiento de la hipertensión arterial: Programa 20-20.Revista Colombiana de Cardiología. 2019;26(2):99-106.

  27. Tesser CD. Why is quaternary prevention important in prevention? Revista de saude publica. 2017;51:116.164




2020     |     www.medigraphic.com